Objectives-To determine if increasing physical activity is protective of diaphysial (cortical) bone mass Methods-Fifteen patients attending two rheumatology clinics who had developed seropositive or classical rheumatoid arthritis up to 26 months previously were studied prospectively for two to three years. Rates of loss (or gain) in bone mass in the radial diaphysis and the trabecular bone ofthe distal radius were measured by quantitative computed tomography, and in the spine by dual photon absorptiometry. Physical activity was assessed by the Framingham physical activity index. Disease activity was followed at threemonthly clinic visits at which the haemoglobin, erythrocyte sedimentation rate, and platelet count were measured. The urinary hydroxyproline to creatinine ratio and plasma osteocalcin were measured at the beginning and end of the observation period.
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Objectives-To determine if increasing physical activity is protective of diaphysial (cortical) bone mass Methods-Fifteen patients attending two rheumatology clinics who had developed seropositive or classical rheumatoid arthritis up to 26 months previously were studied prospectively for two to three years. Rates of loss (or gain) in bone mass in the radial diaphysis and the trabecular bone ofthe distal radius were measured by quantitative computed tomography, and in the spine by dual photon absorptiometry. Physical activity was assessed by the Framingham physical activity index. Disease activity was followed at threemonthly clinic visits at which the haemoglobin, erythrocyte sedimentation rate, and platelet count were measured. The urinary hydroxyproline to creatinine ratio and plasma osteocalcin were measured at the beginning and end of the observation period. Results-Eleven patients required treatment with disease modifying drugs but none was given corticosteroids. Those We have therefore examined prospectively whether the PAI is a predictor of bone conservation in three sites: the spine, the distal radius, and the radial diaphysis. At these sites the dispersion of bone loss rates was greater in a group of patients with early RA than in controls (variance ratios F; for spine F=2-61, p=0.05; for radial diaphysis F=3-36, p<OO25),6 suggesting that some factor associated with RA and its evolution was causing individual bone density trends to diverge more than is seen normally. Because of the possibility that the observed correlation between PAI (or PAI changes) and diaphysial bone mass changes could be confounded by an effect of disease activity, results are presented with and without adjustment for mean levels of the three markers of disease activity that were regularly measured-that is, ESR, haemoglobin concentration, and platelet count. Significance levels for the two bone measurement sites distant from active disease were adjusted by a factor of two because two sites were measured (Bonferroni correction).
Patients and methods

Results
All but four patients showed some improvement in their PAI and the mean value increased significantly (initial mean (SD) PAI 30d1 (2) (3) (4) (5) (6) , mean improvement 3-53 (5 58); p=003). The four patients not requiring disease modifying drugs did relatively better in this respect (mean improvement +9-6 v +07 in those requiring disease modifying drugs; p<OOl). The change in PAI was strongly and inversely related to diaphysial bone loss in the radius (figure), the regression shown accounting for 48-5% of the variance in diaphysial bone loss. A similar relation was seen in the 11 patients receiving disease modifying drugs when considered separately. Much less of the variance in radial trabecular or lumbar spinal bone loss rates was accounted for (100 and 1 1% respectively; p>005). When the final value of the PAI over the time of observation was used as the independent variable, the results were similar (the percentages of variance accounted for were 54-7, 9 4, and 6-6% respectively).
The final measurements of the three indices relating to bone turnover, the plasma osteocalcin, the urinary hydroxyproline to creatinine ratio, and the urinary calcium to creatinine ratio were corfelated with the concurrent PAI; the PAI was found to explain 10-7, 28-8, and 21-8% of the variance in these indices, suggesting in the case of hydroxyproline (p<005 unadjusted) an inverse relation between physical activity and bone resorption two to three years after recruitment to the study. The mean rate of diaphysial bone loss showed some correlation with the mean ESR (r=-0A42; p=0 1), suggesting a weak relation between sustained disease activity and loss of diaphysial bone. When the relation between rate of diaphysial bone loss with the change in PAI was adjusted in turn for mean levels of the three indices of disease activity (ESR, platelet count, and haemoglobin concentration), however, the strength of the relation between physical activity and bone conservation was There was no significant difference in mean bone loss rates at any of the three sites between those patients who were and were not treated with disease modifying drugs (p>005), nor did diaphysial bone loss rates correlate with age or years since the menopause (p>005). The postmenopausal group lost 1-6% more diaphysial bone than the premenopausal women, but this was not significant (p>005). Adjusting the correlations of bone loss with physical activity for age or menopausal status had little effect.
Discussion
These observations show an impressive relation between recovering physical activity in response to treatment of RA and protection against further diaphysial (cortical) bone loss from the radius. The inverse relation between the use of disease modifying drugs and the improvement of the PAI presumably reflects the use of these drugs in those patients whose disease was more severe. Like Sambrook et al in their cross sectional study,4 we could not confirm an independent effect of physical activity on spinal bone loss. Near inflamed joints other factors appear to be more important. We showed previously that bone loss from the distal radius, adjacent to the inflamed wrist joint, was related to plasma levels of parathyroid hormone and calcitriol.6
Physical activity and bone conservation in RA As the worker (PNS) who initially assessed these patients had returned to Australia, it was not possible to compare formally the results obtained by the two PAI assessors. As all the first round of PAI values were obtained by PNS and all the second round by DS, any bias that may have arisen is likely to have been consistent. We compared the calculated bone density trends with final PAI values (depending on the results of only one assessor) as well as with changes in the PAI, and the conclusions drawn were similar. The Framingham index is comparatively simple, easily understood, and robust. For some purposes it may be thought insensitive, but a broad range of values was found in these patients after two to three years of observation.
The biochemical investigations suggest that in those patients who are less active bone resorption is increased, whereas physical activity may prevent bone loss by suppressing bone resorption. It is possible that the different responses of the radius and spine reflect a more substantial effect of active disease on inhibiting the mechanical use of the forearm compared with the spine. Verstraeten and Dequeker3 showed that in patients with RA not treated with corticosteroids the radial diaphysial bone mass was significantly reduced compared with controls. Als et al9 found, in a cross sectional study, that reductions of forearm bone mineral content were associated with the degree of functional impairment and that biochemical markers of bone remodelling such as plasma osteocalcin (formation) and urinary hydroxyproline (resorption) increased as function was impaired.9 Alternatively, the increased urinary hydroxyproline in those less active may reflect disease activity as urinary hydroxyproline is also derived from the complement component Clq, the turnover of which is also increased in RA.10 In another study, Sambrook et al" found that hip and spine bone loss responded differently to exogenous oestrogen treatment in postmenopausal women with RA, with no apparent protection being conferred at the hip. These findings suggest the mechanisms of spinal bone loss in postmenopausal women with RA may be different from those responsible for bone loss in long bones.
In our previous study based on these patients, 6 we found that loss of trabecular bone from the distal radius about 2 5 cm from the inflamed wrist joint was much more rapid than from other sites and was statistically positively associated with plasma parathyroid hormone and calcitriol levels. It seemed possible that these circulating hormones might interact biochemically with local mediators of increased bone resorption, such as interleukin 1, to amplify juxta-articular bone loss in the vascular 6 territory of the wrist joint.
In conclusion, early disease control allowing the resumption of pre-disease levels of physical activity may be the most effective means of preventing bone loss from the cortices of the peripheral skeleton and might reduce the otherwise increased risk of disabling long bone fractures in later life. Other approaches will be required to control juxta-articular bone loss. 
